Nice summary! After 9 years in the pharma commercialization industry, I'd like to add that sometimes Phase II/III occur together for rare diseases since it takes so long and is so hard to enroll all patients. Data releases from P2 and P3 are huge days for pharma companies.
Nice summary! After 9 years in the pharma commercialization industry, I'd like to add that sometimes Phase II/III occur together for rare diseases since it takes so long and is so hard to enroll all patients. Data releases from P2 and P3 are huge days for pharma companies.
Thanks Barbara! Yeah, there are definitely more details in here that I omitted, thanks for the added color!